ProCE Banner Series

ASCO Data Updates for Dual IO Combination Therapy for the Treatment of Unresectable or Metastatic Melanoma

Key updates from ASCO in the advancements of DUAL IO therapies for metastatic melanoma and how the treatment options are improving outcomes for patients.

Key Takeaway:
- Treating patients with unresectable or Metastatic Melanoma with BRAF Status or Wild Type

All Events

ASCO® Data Updates for Dual IO Combination Therapy for the Treatment of Unresectable or Metastatic Melanoma

Past Events

July

24

2024

12:15 PM - 1:00 PM Central Time (CT)

Virtual

Faculty

ProCE Banner Faculty
Daniel H. Johnson, MD

Deputy Director of Precision Therapies Program
Ochsner, MD Anderson Cancer Center